Frequently Asked Questions

Our technology is built on a robust algorithm that integrates with electronic health records (EHR) to analyze a wide array of patient data, including demographics, medical history, diagnosis codes, lab results, and other relevant clinical information. We ensure accuracy by continually training our AI with the latest clinical trial criteria and cardiology guidelines. Additionally, we have fail-safes in place that flag potential discrepancies for review by our clinical team, ensuring that pre-screening is both reliable and accurate.

Protecting patient privacy is of utmost importance. Our system is designed to be fully compliant with HIPAA and other relevant regulations. We use encryption, access controls, and auditing trails to safeguard personal health information. All data is anonymized and used strictly for the purposes of identifying eligible patients for clinical trials.

Yes, our software is designed to be interoperable with various EHR systems. We have a dedicated integration team that works closely with your IT department to ensure a seamless setup. Our goal is to make the pre-screening process as efficient as possible without disrupting your existing workflows.

Our AI employs advanced natural language processing (NLP), optical character recognition (OCR) and

other machine learning solutions to interpret and apply complex eligibility criteria. It can understand a range of clinical trial requirements and assess them against patient data extracted from EHRs. Moreover, our system is continuously learning from trial outcomes and feedback to improve its understanding of nuanced criteria, thereby improving its pre-screening capabilities over time.

If a discrepancy or question arises regarding a patient’s eligibility after AI pre-screening, the case is flagged for manual review by our clinical specialists. We work in close collaboration with the trial coordinators and cardiologists at the outpatient clinic to review the patient’s data thoroughly and ensure all eligibility criteria are met before proceeding with recruitment. Communication channels are always open for discussing any aspects of patient eligibility and trial requirements.